In bacteria various sugars are taken up and concomitantly phosphorylated by sugar-specific enzymes II (EII) of the phosphoenolpyruvate:sugar phosphotransferase system (PTS). The phosphoryl groups are donated by the phosphocarrier protein HPr. BglG, the positively acting regulatory protein of the Escherichia coli bgl (β-glucoside utilization) operon, is known to be negatively regulated by reversible phosphorylation catalyzed by the membrane spanning β-glucoside-specific EII Bgl . Here we present evidence that in addition BglG must be phosphorylated by HPr at a distinct site to gain activity. Our data suggest that this second, shortcut route of phosphorylation is used to monitor the state of the various PTS sugar availabilities in order to hierarchically tune expression of the bgl operon in a physiologically meaningful way. Thus, the PTS may represent a highly integrated signal transduction network in carbon catabolite control.
Introduction
Although it was initially thought that different mechanisms of signal transfer may exist for the three kingdoms of life, it has recently been discovered that eukaryotic-type protein kinases are also found in prokaryotes (for a review see Zhang, 1996) , whereas two-component systems, which were thought to be restricted to bacteria, were found to be involved in eukaryotic signaling (for reviews see Loomis et al., 1997; Wurgler-Murphy and Saito, 1997) . In contrast, the phosphoenolpyruvate:sugar phosphotransferase system (PTS), which is ubiquitous in bacteria, seems to be bacteria specific. The PTS is not only central in uptake and phosphorylation of various sugars, but also mediates chemotaxis towards these sugars, as well as transcriptional regulation of numerous genes (for reviews see Postma et al., 1993; Saier and Reizer, 1994) .
The PTS catalyzes phosphotransfer reactions from phosphoenolpyruvate to various sugars, a process which involves at least three proteins. First, enzyme I (EI) autophosphorylates with phosphoenolpyruvate, and then donates the phosphoryl group to histidine protein (HPr), which in turn phosphorylates the respective sugar-specific transport proteins enzymes II (EII) from which phosphate is transferred to the incoming sugar concomitantly with its transport. EIIs consist of at least three functionally different domains, IIA, IIB and IIC, which may be present on the same polypeptide chain or may be encoded by different genes. The phosphocarrier protein HPr phosphorylates the respective EIIs at a histidine residue in the IIA domain, from which phosphate is transferred to a residue of the IIB domain, in most cases a cysteine, and then to the sugar. Membrane bound domain, IIC, forms the translocation channel and the sugar-specific substratebinding site.
The PTS is also central in carbon catabolite repression, exerted in Gram-negative bacteria by the glucose-specific IIA Glc (formerly EIII Glc ). Phosphorylated IIA Glc is thought to activate adenylate cyclase, whereas non-phosphorylated IIA Glc binds and inhibits various proteins concerned with uptake and metabolism of non-PTS sugars. This mechanism may, therefore, explain preferred utilization of some PTS carbohydrates over non-PTS carbohydrates. Preferential utilization of one PTS sugar over another has also been observed several times, but the cause of this hierarchical utilization remained unclear (Postma et al., 1993) .
The transcriptional regulator BglG from Escherichia coli regulates expression of the bgl operon, encoding proteins concerned with regulated uptake and utilization of β-glucosidic sugars (Prasad and Schaefler, 1974; Schnetz et al., 1987) . BglG was the first identified member of a fast-growing family of related proteins shown to be directly regulated by the PTS in a substrate-dependent manner (Rutberg, 1997; Tortosa et al., 1997; Stülke et al., 1998) . BglG is the product of the first gene of the operon and acts as a transcriptional antiterminator at two ρ-independent terminators within the operon Schnetz and Rak, 1988) . The second gene of the operon, bglF, encodes the β-glucoside-specific EII Bgl , which is a member of the PTS-family of sugar transport proteins. EII Bgl has also been shown to be a negative regulator of BglG . In the absence of substrate, when phosphate cannot be transferred to the sugar, EII Bgl phosphorylates and concomitantly inactivates BglG, thereby preventing transcription of the operon. When β-glucosides become available, EII Bgl dephosphorylates and thereby reactivates BglG (AmsterChoder et al., 1989; Amster-Choder and Wright, 1990; .
In this report we re-investigated regulation of BglG activity. Data presented show that to be active, BglG requires the presence of the general PTS proteins, EI and HPr. Complementation analysis revealed that phosphoHPr is necessary for activation and that the diphosphoryl transfer protein (DTP), which shares an HPr-like domain, can substitute for HPr in this process. Furthermore, we show that BglG is phosphorylated in vivo in a PTSdependent reaction also in the absence of EII Bgl , suggesting that HPr activates BglG by phosphorylation and that BglG requires an intact PTS to be active, but its overproduction can partially overcome this requirement. Antitermination reporter plasmid pFDY226 (A) was cotransformed with bglG expression plasmid pFDX2469 (B) into E.coli strain R1279 (pts ϩ ; white histograms) and its isogenic Δpts derivative R1653 (shaded histograms). Increasing levels of BglG synthesis were driven by increasing concentrations of inducer (IPTG) and β-galactosidase activity was determined as a measure for antitermination activity. The ratio of enzyme activity synthesized by the two strains is given as filled triangles. For IPTG concentrations below 50 μM enzyme activity remained at background levels with the Δpts strain which was 37 units for both strains when transformed with the antitermination test plasmid alone (dotted line).
two different and antagonistically acting phosphorylation reactions control BglG activity. When we investigated the possible role of this positively acting HPr-mediated phosphorylation, we found that this mechanism may function to downregulate BglG activity and thus bgl operon expression when other, more favorable PTS sugars become available, by draining the activating phosphoryl groups away from BglG. This control, which makes use of the reversible flow and limited pool of transferable phosphoryl groups within the PTS, represents an unprecedented level of carbon catabolite control in E.coli.
Results

BglG requires the PTS for its activity
To determine antitermination activity of BglG, we made use of our antitermination reporter plasmid described previously (Schnetz et al., 1996) . In this plasmid ( Figure  1A ) the lacZ reporter gene is preceded by terminator t2 of the bgl operon (bgl-t2) which in the absence of the active BglG protein blocks elongation of transcription initiated at constitutive promoter P16. Also present on the plasmid is the lacI q gene providing the lac repressor for the controlled expression of bglG which is under tacOP control on a second plasmid ( Figure 1B ). In the absence of the bglG-containing plasmid, 37 units of β-galactosidase activity were synthesized in a wild type strain background as well as in an isogenic background carrying a deletion 3371 (Δpts) which encompasses genes ptsH, ptsI and crr encoding HPr, EI and IIA Glc , respectively. This low activity reflects the leakiness of terminator t2 (Schnetz and Rak, 1988 ; dotted line in Figure 1B ). In the presence of the bglG expression plasmid, and with increasing concentrations of isopropyl-β-D-thiogalactopyranoside (IPTG) as inducer for BglG synthesis, enzyme activity increased in the wild type background from 177 units (no IPTG) to 1776 units (2 mM IPTG). In the pts deletion strain, enzyme activity did not start to rise above background at concentrations below 0.05 mM IPTG (49 units) and only reached 676 units at saturating concentrations (2 mM). Moreover, the ratio of enzyme activities (wt/Δpts) decreased with increasing IPTG concentrations from 14.1 (0.05 mM) to 2.6 (2 mM), indicating that BglG requires an intact PTS for full activity and that this requirement can be partially overcome by overproduction of BglG. To support this conclusion we verified that deletion of the pts operon does not negatively influence gene expression within our detection system. To this end we employed transformants carrying a plasmid (pFDY225), which is identical to the antiterminator test plasmid ( Figure 1A ) but lacks the bgl terminator. In addition we employed a plasmid (pFDX3549), which is isogenic to the BglG expression plasmid ( Figure 1B ) but carries the lacZ gene instead of bglG. Indeed, enzyme activities directed by these plasmids in the wild type strain were not significantly different from those synthesized in the isogenic pts deletion derivative (data not shown).
Activation of BglG requires phospho-HPr or phospho-DTP
Next we wanted to define in more detail the requirements for activation of BglG by the PTS. To avoid the problems imposed by overproduction of BglG due to high gene dosage with multi-copy plasmids, we inserted the tacOPdriven bglG expression cassette either with ( Figure 2B ) or without the bglF gene (encoding EII Bgl ) ( Figure 2C ) into the chromosome. The different strain backgrounds used together with complementing plasmids are given in Figure 2A . As can be seen from the data, β-galactosidase activity was low in all cases when IPTG was omitted. As expected, it remained low in the presence of IPTG when bglF was coexpressed together with bglG in the wild type strain and increased to 325 units when salicin was added as substrate for bglF-encoded EII Bgl ( Figure 2B , column 1) reflecting the relief from negative control exerted by the phosphorylated EII Bgl on BglG activity (see Introduction). Likewise, BglG activity was constitutive and high in the absence of bglF ( Figure 2C , column 1). In the Δpts background (columns 2), β-galactosidase activities were reduced to background levels verifying the PTS dependence of BglG activity demonstrated above. Activation of BglG as well as its negative regulation were fully complemented when HPr together with EI were expressed from a plasmid (columns 3). Expression of HPr alone did not result in complementation (column 4), whereas expression of EI alone led to partial complementation (columns 5). HPr thus appears not to be absolutely required for activation and negative control of BglG. However, it has been reported that a defect in HPr can be complemented for PTS sugar transport in mutants defective for fruR (Saier and Ramseier, 1996) . The repressor FruR negatively BglG requires phospho-HPr for activation which can be substituted by phospho-DTP. Genes bglG and bglF (B) or bglG alone (C) under tacOP control were integrated into the chromosome by site-specific recombination to obtain single-copy situations and subsequently crossed into various strain backgrounds harboring different expression plasmids (A) also driven by tacOP and thus inducible by IPTG. In addition, antitermination reporter plasmids pFDX2676 or pFDX3158 were present. These plasmids are identical to plasmid pFDY226 ( Figure 1A ) but carry, for compatibility reasons, different antibiotic resistance markers. Inducers were added as indicated in the figure and β-galactosidase activities were determined as described in Materials and methods with the exception of lane 6. In these experiments, cells were pregrown in M9-fructose medium which was substituted by M9-glycerol at the time point when inducers were added. This was necessary to avoid interference of BglG activity due to transport of fructose (a PTS-sugar) (see data below and Discussion). The following strains were employed: in (B) lane 1, R1752; lanes 2-6, R2013; lane 7, R1971; lanes 8-13, R1977. In (C) lane 1, R1958; lanes 2-6, R2051; lane 7, R1974; lanes 8-13, R1979. These strains harbored the following plasmids: (B and C) lanes 1 and 2 and 7 and 8, pFDX2676; lane 3, pFDX2676/pFDX3155; lanes 4 and 9, pFDX3158/pFDX3160; lanes 5, 6 and 10, pFDX3158/pFDX3161; lane 11, pFDX3158/pFDX3221; lane 12, pFDX2676/pFDX3155; lane 13, pFDX3158/pFDX3223. controls the fructose inducible fru operon which codes for fructose-specific PTS functions and a fructose-1-phosphate kinase. Responsible for the complementation is the product of the fruB gene, DTP (diphosphoryl transfer protein), which carries a domain homologous to HPr. DTP thus was a good candidate which possibly could substitute for HPr in BglG control. We therefore repeated the experiment shown in columns 5 with a culture pregrown in fructose as inducer of the fru operon. This pretreatment indeed resulted in better complementation of activation as well as negative control of BglG activity (columns 6). Consequently, we analyzed the involvement of fru operon functions. Deletion of the operon in the wild type strain had no appreciable effect (compare columns 1 and 7). We next crossed in the pts deletion resulting in the doubledeletion strain Δpts,Δfru. As expected, enzyme activities were equally low in this strain as in the strain carrying the pts deletion (compare columns 2 and 8). They remained low when the defects were complemented by a ptsH (HPr) or ptsI (EI) expression plasmid (see columns 9 and 10). We can thus conclude that restoration of BglG activity and its negative control in the pts deletion strain expressing EI (columns 5 and 6) is due to a function encoded by the fru operon. Since the likely candidate is DTP, we complemented the double-deletion strain with an artificial operon encompassing fruB (DTP) and ptsI(EI). As can be seen from the data in column 11, the activity of BglG as well as its negative control were fully restored. It was likewise restored when the strain expressed ptsH and ptsI (columns 12), but not when the ptsH gene was replaced by an allele carrying a point mutation within the phosphorylation site (columns 13). Together, the data indicate that BglG is activated by the PTS and that this activation requires phosphorylated HPr, which can be substituted by the phosphorylated form of DTP.
BglG is phosphorylated by the PTS even in the absence of EII Bgl
The requirement for phosphorylated HPr suggested that activation of BglG might involve HPr-catalyzed phosphorylation of BglG. This possibility was studied by in vivo phosphorylation of BglG. Strains carrying various plasmids with the relevant genes cloned downstream of tacOP were pulse labeled with H 3 [ 32 P]O 4 in the presence or absence of IPTG as inducer, and the proteins were separated on SDS-PAGE. The resulting autoradiographs are shown in Figure 3 . First we reproduced the EII Bgldependent BglG phosphorylation demonstrated previously (Amster-Choder et al., 1989; Amster-Choder and Wright, 1990; . When compared with the untransformed strain ( Figure 3A , lane 1), a signal corresponding to the BglG protein can be observed without IPTG ( Figure 3A , lane 2), and this signal increased strongly when IPTG was added ( Figure 3A, lane 3) . As expected from the previous data, the presence of salicin as substrate for EII Bgl transport completely inhibited Transformants of strains R1279 (pts ϩ ) and R1653 (Δpts) were grown with or without IPTG (0.1 mM) as inducer for tacOP driven expression of plasmid-encoded genes. Where indicated, salicin as substrate for EII Bgl was added. Lac repressor was provided from a second plasmid (pFDY226) with the exception of lane 7 (marked with an asterisk), where the lacI gene was present on the bglG-containing plasmid. In this case the plasmid had an increased copy number and 1 mM IPTG was added as inducer. Aliquots of cultures were labeled with H 3 [ 32 P]O 4 , proteins separated by SDS-PAGE and gels subsequently exposed to X-ray films. Lane 1, R1279 (empty strain); lanes 2-4, R1279/pFDX3102 (bglG, bglF); lanes 5 and 6, R1279/ pFDX2942 (bglG); lane 7, R1279/pFDY45 (bglG); lane 8, R1653/ pFDX2942 (bglG); lane 9, R1653 (empty strain); lanes 10 and 11, R1279/pFDX3225 (galKΦbglG); lanes 12-14, R1279/pFDX3226 (galKΦbglG, bglF). (B) Massive PTS-sugar transport completely prevents phosphorylation of BglG in the absence as well as in the presence of EII Bgl . Transformants of strain R1279 were labeled as described in (A). In contrast to (A), gene bglF controlled by tacOP was provided by a lacI-containing plasmid (pFDX3283) in trans. IPTG as inducer for gene expression and sugars salicin, N-acetyl-Dglucosamine or mannitol as substrates for their respective EIIs were added where indicated. Lane 1, R1279 (empty strain); lanes 2 and 3, R1279/pFDX2942 (bglG)/pFDY226; lanes 4 and 5, R1279/pFDX3293 (bglG, nagE)/pFDY226; lanes 6 and 7, R1279/pFDX3295 (bglG, mtlA)/pFDY226; lanes 8-10, R1279/pFDX2942 (bglG)/pFDX3283 (bglF); lanes 11 and 12, R1279/ pFDX3293 (bglG, nagE)/pFDX3283 (bglF); lanes 13 and 14, R1279/pFDX3295 (bglG, mtlA)/pFDX3283 (bglF).
phosphorylation of BglG ( Figure 3A, lane 4) . However, when bglG was expressed alone, an IPTG-dependent signal appeared at the position of BglG ( Figure 3A , lanes 5 and 6). It disappeared when the same experiment was carried out with the pts deletion strain ( Figure 3A , lanes 8 and 9). To unambiguously verify that the signal detected in the absence of EII Bgl is due to the phosphorylated BglG protein, we repeated the experiments in the wild type strain with a galK-bglG fusion which expresses a protein with an increased molecular weight and for which EII Bgldependent phosphorylation has previously been shown . Phosphorylated species were 3373 indeed observed at the expected positions and in an IPTGdependent manner, not only in the presence of EII Bgl ( Figure 3A , lanes 12 and 13) but also in its absence ( Figure 3A, lanes 10 and 11) . Again, no phosphorylation was observed in the presence of EII Bgl when salicin was present ( Figure 3A, lane 14) . As a control for BglG expression levels we performed [ 35 S]methionine pulsechase labeling and SDS-PAGE with the identical transformants used in Figure 3A and in the presence or absence of IPTG and salicin as given in the figure. The resulting autoradiograph revealed that neither coexpression of EII Bgl together with BglG nor the strain employed nor the presence of salicin had any appreciable effect on the amount or stability of BglG produced (data not shown), thus indicating that differences in 32 P-signal strengths of BglG at identical IPTG concentrations reflect differences in the efficiency of BglG phosphorylation rather than differences in the amount of protein present. We also learned from this series of experiments that care had to be taken in adjusting the expression level of BglG. A 5-fold higher expression (as revealed from the [ 35 S]methionine labeling; data not shown) resulted in an almost complete loss of the HPr-dependent phosphorylation signal of BglG ( Figure 3A, lane 7) . This effect could be attributed to the formation of insoluble inclusion bodies (Krieg, 1993; Chen et al., 1997a) which may sequester most of the available BglG protein. It may also explain why EII Bglindependent phosphorylation previously remained undetected .
Underphosphorylation of the PTS leads to dephosphorylation and concomitant inactivation of BglG
According to previous models (see Introduction) EII Bgl , in the absence of β-glucosidic substrates, inhibits BglG by phosphorylation and reactivates it by dephosphorylation when substrates become available (negative-feedback control). The data presented above extend this model and demonstrate that activity of BglG is additionally under positive control of the PTS, dependent upon HPr-catalyzed phosphorylation, which should occur at a different site than that catalyzed by EII Bgl . However, the observation that the presence of salicin as sugar substrate completely prevents phosphorylation of BglG ( Figure 3A , lanes 4 and 14) at first seemed to contradict this conclusion. One has to bear in mind, however, that analysis of BglG activity (Figure 2 ) required single-copy situations, while the salicin-dependent dephosphorylation of BglG, which was performed under in vivo conditions ( Figure 3A ), could only be demonstrated when bglG and bglF were overexpressed from a plasmid. We therefore reasoned that the HPrcatalyzed phosphorylation of BglG was prevented due to massive salicin transport catalyzed by unphysiologically high concentrations of EII Bgl . This might drain the entire phosphorylation capacity of the PTS towards the incoming sugar. To investigate this possibility, we performed two types of analysis. We analyzed phosphorylation of BglG expressed from a plasmid ( Figure 3B ) and in parallel studied the activity of BglG expressed from a single-copy gene, in both cases in the presence of overproduced EIIs other than EII Bgl (Figure 4) . To indicate the position of the phosphorylated form of BglG and IPTG dependence of its expression, the phosphorylation assays shown in Fig. 4 . Massive PTS sugar transport drastically decreases BglG activity. Strains R1752 and R1958 carrying tacOP-controlled genes bglG-bglF and bglG, respectively, integrated into the chromosome were cotransformed with antitermination reporter plasmid pFDX2676 and one of the following plasmids for tacOP-controlled expression of different EIIs (where indicated): pFDX3297 (nagE; EII Nag ), pFDX3298 (mtlA; EII Mtl ), pFDX3299 (bglF; EII Bgl ). Given are β-galactosidase enzyme activities synthesized by these transformants in presence or absence of IPTG as inducer for gene expression and the various PTS sugar transport substrates. -, not determined. Figure 3A , lanes 1, 5 and 6, were repeated in Figure 3B , lanes 1, 2 and 3, respectively. Neither overexpression of nagE (encoding EII Nag ) nor that of mtlA (encoding EII Mtl ) led to significant alterations in the state of phosphorylation of BglG ( Figure 3B , lanes 4 and 6, respectively). The presence of the respective sugar substrates, N-acetyl-D-glucosamine (Nag) and D-mannitol (Mtl), however, completely prevented phosphorylation of BglG ( Figure  3B , lanes 5 and 7). Lanes 8-10 correspond to lanes 2-4 in Figure 3A , with the difference that EII Bgl was delivered from a second plasmid in trans. Again, the phosphorylated form of BglG appeared in an IPTG-dependent manner ( Figure 3B , lanes 8 and 9) and disappeared when salicin was present (lane 10). As expected, this pattern did not alter, when in addition, nagE (lane 11) or mtlA (lane 13) was expressed as an operon fusion with bglG. However, the presence of the respective sugar substrates (Nag; Figure 3B , lane 12 or Mtl; lane 14) almost completely prevented phosphorylation of BglG. Again, we verified by [ 35 S]methionine pulse-chase labeling and SDS-PAGE with the identical transformants that the conditions employed had no unexpected effects on the expression level of BglG (data not shown). We can thus conclude that massive transport of a PTS substrate generally causes disappearance of the phosphorylated form of BglG, regardless of the presence of EII Bgl .
To correlate the phosphorylation data with the activity of BglG, we performed the antitermination assay with the transformants used in Figure 2 , columns 1. These cells were transformed with additional plasmids carrying nagE, mtlA or bglF under tacOP control (Figure 4 ). For comparison, the values without an additional plasmid (taken from Figure 2 , column 1) are also included. It can be seen that the additional expression of nagE in the absence of N-actetyl-D-glucosamine (Nag) as substrate, or mtlA in the absence of D-mannitol (Mtl) did not influence the BglG activity originating from the bglG gene or the bglG-bglF operon. In contrast, the presence of the respective sugar substrates reduced activity to nearly background, not only when the bglG gene was expressed alone, but also when the bglG-bglF operon was expressed and salicin was included as inducer. These results support the notion derived from the phosphorylation data that phosphoryl groups within the PTS may be limiting for the activation of BglG. They support our conclusion that BglG must be phosphorylated in order to be active. Further support is derived from the data in the last column in Figure 4 : overexpression of bglF from a plasmid in the strain containing bglG alone led to a drastic reduction of BglG activity even in the presence of salicin, and reduced it to almost background levels in the strain carrying the bglGbglF operon.
Does the limitation of phosphoryl group availability play a role under physiological conditions?
We wanted to learn whether the inhibitory effect on BglG activation seen under conditions of overproduction of EIIs and in the presence of the respective sugar substrates points to a limited pool of phosphoryl groups under more physiological conditions. From this we hoped to learn more about its possible role in keeping the activity of BglG low under natural conditions when other, perhaps more favorable sugars are available. To this end we performed the antitermination assay as in Figure 2 , columns 1 but replaced glycerol with other sugars. In the case of the bglG-bglF operon, salicin was in addition present as substrate for EII Bgl and thus as inducer of BglG activity. The results are given in Figure 5 . Glycerol is a non-PTS sugar, while the other sugars used are all substrates of the PTS. Compared with glycerol, all PTS sugars indeed led to a reduction of BglG activity to different extents.
Discussion
In view of the previous finding that the PTS negatively controls activity of BglG by EII Bgl -catalyzed phosphorylation it might have been expected that any mutation Fig. 5 . Utilization of PTS sugars reduces BglG activity to different degrees. Strains R1958 (light gray histograms) and R1752 (dark gray histograms) carrying the chromosomally integrated tacOP driven bglG and bglG-bglF expression cassettes, respectively, were transformed with antitermination reporter plasmid pFDX2676. Cells were grown in M9-medium with the indicated sugar as carbon source. IPTG was added to induce synthesis of BglG and BglG together with EII Bgl , respectively. In the case of R1752 salicin was additionally present to release BglG from negative control exerted by EII Bgl .
preventing this phosphoryl group transfer would result in unrestrictedly high activity of BglG. Indeed, activity of BglG was high and constitutive in the absence of EII Bgl (Figures 1 and 2 ) or when cysteine residue 24 within EII Bgl , the phosphoryl group donor site for BglG phosphorylation, was replaced by a serine (Krieg, 1993; Chen et al., 1997a) . However, contrary to expectation, BglG turned out to be inactive when the central energy-coupling proteins of the PTS, EI and HPr, were absent (Figure 2) , suggesting a second level of BglG activity control requiring the PTS. Since evidence has been presented that the active form of BglG is a dimer (Amster-Choder and Wright, 1992) , the positively acting signal may be necessary for dimer formation. This requirement can, however, be overcome, at least in part, by an increase in its concentration above the physiological level (Figure 1 ). Similar observations have been reported for LicT of the BglG family of antiterminators (Krüger and Hecker, 1995; Krüger et al., 1996) and the related transcriptional activator LevR (Stülke et al., 1995) . Detailed genetic complementation analyses revealed that phospho-HPr is required for BglG activity, and it turned out that for this activation, HPr can be substituted by DTP, a component of the fructose-inducible PTS encoded by the fru operon. Suppression of HPr deficiency by DTP has been observed before for PTS transport functions, either in mutants lacking the fru repressor (Saier and Ramseier, 1996) or in cultures induced with fructose (Saier et al., 1970) . The possible physiological role of the cross-talk observed here for BglG activation remains to be determined.
Since our results suggested that BglG might be directly phosphorylated by HPr, we performed in vivo phosphorylation analyses. Indeed, phosphorylated BglG species were detected in the absence of EII Bgl , under conditions where BglG activity was constitutively high (Figure 3) . On the other hand, BglG was inactive and not phosphorylated when expressed in a Δpts strain background. We therefore extend the previous model and conclude that activation of BglG might require both dephosphorylation by EII Bgl and simultaneous phosphorylation by HPr (see model in Figure 6B ). In the presence of EII Bgl and in the absence of β-glucosides (and any other PTS sugars; see below) we observed a stronger signal for phospho-BglG ( Figure  3A) , suggesting that BglG might be doubly phosphorylated under these conditions ( Figure 6A ). Since this form is not active, inactivation of BglG by EII Bgl -dependent phosphorylation may be dominant over that exerted by HPr.
The conclusion drawn in previous works, that the completely dephosphorylated form of BglG may be the active form, was derived from experiments demonstrating that BglG is completely dephosphorylated in the presence of EII Bgl and β-glucosidic substrates under in vivo (AmsterChoder and Wright, 1990; ; this work) as well as in vitro conditions (Amster-Choder et al., 1989) . This conclusion seems to contradict our model that BglG must be activated by HPr-mediated phosphorylation. According to the model proposed in Figure 6B , one might expect the addition of β-glucosides should lead to the appearance of a monophosphorylated form of BglG, since activation of BglG seems to require both dephosphorylation by EII Bgl at one site and simultaneous phosphorylation by HPr at a distinct site. However, it has been proposed that only a limited pool of phosphoryl groups is available within the PTS due to slow autophosphorylation of EI (Meadow et al., 1990; Chauvin et al., 1994; Fomenkov et al., 1998) . Furthermore, the phosphoryl groups appear to be exchangeable within the PTS due to the exceptionally high phospho-transfer potential of the PTS phosphoproteins, which is conserved until their transfer to the sugar substrate (Weigel et al., 1982) . These characteristics are thought to form the basis for a wide variety of regulatory processes like the stringent regulation of sugar uptake and catabolite repression exerted in E.coli by the ratio [phospho-IIA Glc ]/[IIA Glc ] (Postma et al., 1993; Hogema et al., 1998) or chemotaxis towards PTS substrates, which is believed to monitor the phosphorylation state of EI (Lux et al., 1995) . These characteristics also provide an explanation for the apparent contradiction: since in all in vivo BglG phosphorylation experiments carried out until now, EII Bgl was provided in much higher concentrations than normally present inside the cell, it is conceivable that phosphoryl groups from HPr were all drained via EII Bgl by the incoming β-glucoside. This would leave BglG in an unphosphorylated form and mask its HPr-catalyzed phosphorylation which occurs under normal conditions. To investigate whether this inhibition of HPrcatalyzed phosphorylation is generally caused by an overload of the PTS, we not only expressed EII Bgl from a plasmid, but also EII Nag and EII Mtl , respectively, and studied BglG phosphorylation ( Figure 3B ) as well as its activity (Figure 4) . Indeed, plasmid-dependent expression of all these EIIs in the presence of their respective sugar substrates completely abolished phosphorylation of BglG and simultaneously rendered the chromosomally expressed BglG inactive. The inhibitory effect of multiple copies of bglF (EII Bgl ) in trans to a single copy of bglG in the presence of salicin has been noticed before , but an explanation could not be given at that time. The finding that transport of other PTS sugars not only prevents phosphoryl transfer from HPr to BglG but also from HPr to EII Bgl and from there to the EII Bgldependent phosphorylation site of BglG may not be surprising since the K M of EII Bgl for phospho-HPr with 40 μM ) is much higher than the reported K M values of other EIIs (Postma et al., 1993) . Thus, it is conceivable that if only negative control by EII Bgl on BglG takes place, addition of another PTS sugar would result in dephosphorylation and activation of BglG even in the absence of β-glucosidic substrates. Therefore, additional control of BglG activity by HPr might be necessary to maintain BglG in an inactive state, when in the absence of β-glucosides, other PTS sugars are available ( Figure 6C ). To learn whether cells utilize the limited pool of phosphoryl groups within the PTS for regulation of BglG activity under physiological conditions, we examined BglG activity in the presence of various sugars, which were taken up and utilized by the respective chromosomally encoded proteins ( Figure 5 ). Indeed fermentation of all PTS sugars tested lowered BglG activity in the absence as well as in the presence of EII Bgl and its substrate salicin, suggesting that part of the BglG population becomes dephosphorylated and inactivated under natural conditions ( Figure 6C ). Interestingly, PTS sugars differed in their ability to decrease the BglG activity which might reflect a hierarchical order of sugar preference. Hierarchical utilization of PTS carbohydrates has been observed previously (reviewed in Postma et al., 1993) . Since the various EIIA domains of PTS permeases have different K M values for phospho-HPr, it has been proposed that competition for phospho-HPr may be a primary mechanism for the observed hierarchy (Postma et al., 1993) . In the case of control of BglG activity, competition of BglG with the various IIA domains of EIIs for phospho-HPr may determine the level of bgl operon expression and thus the β-glucoside transport capacity of the cell. This represents a novel type of control of gene expression and of carbon catabolite repression in E.coli.
BglG is the prototype of a family of related regulators 3376 all concerned with positive control of catabolic operons encoding proteins that function in uptake and utilization of PTS sugars. Most of these proteins act as antiterminators, but transcriptional activators are also found (for reviews see Rutberg, 1997; Stülke et al., 1998) . They all share two conserved, homologous domains that function as the targets of PTS-mediated regulation and are thus called PTS regulation domains (PRD-1 and PRD-2; Tortosa et al., 1997; Stülke et al., 1998) . Within the PRDs three highly conserved histidine residues are believed to be potential targets of PTS-mediated phosphorylation. Within BglG, these residues are H101 and H160, located in the PRD-1 domain, and H208 located in the PRD-2 domain (Tortosa et al., 1997; Stülke et al., 1998) . Upon examination it has become clear that PRD-containing regulators are negatively regulated by their respective EIIs. For BglG as well as the homologous antiterminators, SacY, SacT and GlcT from Bacillus subtilis, mutants have been isolated which exhibit constitutive activity. Most of these mutations changed the first conserved histidine in PRD-1 or residues around that position Crutz et al., 1990; Debarbouille et al., 1990; Chen et al., 1997b; Bachem and Stülke, 1998) . Thus, it has been proposed that in these antiterminators PRD-1 may be the target of negative regulation exerted by the respective sugar permeases . In addition, it has been reported that activity of some of these PRDcontaining regulators, i.e. antiterminators SacT and LicT and the activator LevR from B.subtilis, are dependent on the presence of EI and HPr (for an overview see Stülke et al., 1998) . In fact, HPr-dependent phosphorylation of these proteins has been demonstrated in vitro (Stülke et al., 1995; Arnaud et al., 1996; Deutscher et al., 1997) . The data presented here do not exclude the possibility that an unknown enzyme mediates the HPr-dependent, PTS-catalyzed phosphorylation in a similar way. Recently it was demonstrated that BglG can be phosphorylated at H208 in vitro and it has been suggested that this site may be the only one phosphorylated (Chen et al., 1997b) . Since in this study, factor Xa cleavage sites were introduced into the PRD-1 domain of BglG, which possibly destroyed its function, it might not be surprising that phosphorylation of the PRD-1 was not detected. Furthermore, our own experiments showed that BglG-H208 mutant proteins were still phosphorylated in vivo (Krieg, 1993; B.Görke and B.Rak, unpublished) , suggesting that there are at least two phosphorylation sites in BglG. Undoubtedly further studies will be necessary to identify the phosphorylation sites on BglG and to clarify the apparently conflicting findings.
Materials and methods
Plasmids and bacterial strains
The relevant structures of plasmids and the genotypes of strains are given in Table I . Plasmids were constructed using standard recombinant techniques (Sambrook et al., 1989) . Details on their construction together with their completely compiled and annotated sequences can be obtained from the [final concentrations: IPTG, 0.1 mM; D-salicin, 7 mM; N-acetyl-Dglucosamine or D-mannitol, 0.5% (w/v)] were added. After pre-incubation at 37°C for 5 min 20 μl M9 containing 20 μCi [ 35 S]methionine were added and further incubated for 2 min. Labeling was terminated by addition of unlabeled methionine (1 mg/ml). After a chase time of 2.5 min cells were collected by centrifugation and after lysis 0.01 OD 600 cells were subjected to SDS-PAGE. Quantitation of radiolabeled bands was carried out by using the bio imaging analyzer FujiXBAS1000 (Fuji Photo Film) and the software PCBAS Tina 2.07c (Raytest).
